Open AccessNusinersen injections in adults and children with spinal muscular atrophy: a single-center experience
Author(s) -
Can Özütemiz,
Peter Karachunski,
David Nascene
Publication year - 2020
Publication title -
diagnostic and interventional radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.754
H-Index - 43
eISSN - 1305-3612
pISSN - 1305-3825
DOI - 10.5152/dir.2020.19607
Subject(s) - medicine , spinal muscular atrophy , single center , center (category theory) , atrophy , pediatrics , physical therapy , physical medicine and rehabilitation , surgery , pathology , disease , chemistry , crystallography
Nusinersen is a drug approved in December 2016 for treatment of spinal muscular atrophy (SMA). We want to share our initial experience with image-guided, non-image-guided, and port-delivered nusinersen injections in a large single-center SMA patient cohort, treating both pediatric and adult patients with focus on technical considerations and other patient concerns from a combined perspective of patient, neurologist, and radiologist.